De Luca, G., Nardin, M., Algowhary, M., Uguz, B., Oliveira, D. C., Ganyukov, V. ... Verdoia, M. (2021). Renin-angiotensin system inhibitors and mortality among diabetic patients with STEMI undergoing mechanical reperfusion during the COVID-19 pandemic. Diabetes Epidemiology and Management, 4.. doi: 10.1016/j.deman.2021.100022
De Luca, Giuseppe, et al. "Renin-angiotensin system inhibitors and mortality among diabetic patients with STEMI undergoing mechanical reperfusion during the COVID-19 pandemic." Diabetes Epidemiology and Management, vol. 4, 2021. https://doi.org/10.1016/j.deman.2021.100022
De Luca, Giuseppe, Matteo Nardin, Magdy Algowhary, Berat Uguz, Dinaldo C Oliveira, Vladimir Ganyukov, Zan Zimbakov, et al. "Renin-angiotensin system inhibitors and mortality among diabetic patients with STEMI undergoing mechanical reperfusion during the COVID-19 pandemic." Diabetes Epidemiology and Management 4 (2021). https://doi.org/10.1016/j.deman.2021.100022
De Luca, G., et al. (2021) 'Renin-angiotensin system inhibitors and mortality among diabetic patients with STEMI undergoing mechanical reperfusion during the COVID-19 pandemic', Diabetes Epidemiology and Management, 4. doi: 10.1016/j.deman.2021.100022
De Luca G, Nardin M, Algowhary M, Uguz B, Oliveira DC, Ganyukov V, and sur.. Renin-angiotensin system inhibitors and mortality among diabetic patients with STEMI undergoing mechanical reperfusion during the COVID-19 pandemic. Diabetes Epidemiology and Management [Internet]. 2021 October [cited 2024 October 07];4. doi: 10.1016/j.deman.2021.100022
G. De Luca, et al., "Renin-angiotensin system inhibitors and mortality among diabetic patients with STEMI undergoing mechanical reperfusion during the COVID-19 pandemic", Diabetes Epidemiology and Management, vol. 4, October 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:196446. [Accessed: 07 October 2024]